Article
Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
5 Dec 2017
Abstract excerpt
Daptomycin remains as one of the main treatment options for Methicillin Resistant Staphylococcus aureus (MRSA). Sporadic resistance cases reported in patients treated with either daptomycin or glycopeptides are a growing concern. In a previous study, we described a clinical case of a patient with a community-acquired MRSA infection resistant to daptomycin and with intermediate resistance to vancomycin who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
